Free Trial

TNF Pharmaceuticals (TNFA) Competitors

TNF Pharmaceuticals logo
$0.56 +0.02 (+3.32%)
As of 10/15/2026

TNFA vs. BOXL, AGMH, WLDS, AIMDW, and CCCXW

Should you buy TNF Pharmaceuticals stock or one of its competitors? TNF Pharmaceuticals's main competitors and comparable companies include Boxlight (BOXL), AGM Group (AGMH), Wearable Devices (WLDS), Ainos (AIMDW), and Churchill Capital Corp X/Cayman (CCCXW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "technology hardware, storage & peripherals" industry.

How does TNF Pharmaceuticals compare to Boxlight?

Boxlight (NASDAQ:BOXL) and TNF Pharmaceuticals (NASDAQ:TNFA) are both small-cap technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.

TNF Pharmaceuticals has a net margin of 0.00% compared to Boxlight's net margin of -20.96%. Boxlight's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Boxlight-20.96% N/A -23.50%
TNF Pharmaceuticals N/A -69.21%-33.98%

Boxlight has a beta of 0.91, suggesting that its stock price is 9% less volatile than the broader market. Comparatively, TNF Pharmaceuticals has a beta of 2.04, suggesting that its stock price is 104% more volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Boxlight
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
TNF Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

TNF Pharmaceuticals has lower revenue, but higher earnings than Boxlight. Boxlight is trading at a lower price-to-earnings ratio than TNF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Boxlight$109.25M0.03-$23.81M-$80.86N/A
TNF PharmaceuticalsN/AN/A-$23.36M-$231.00N/A

In the previous week, Boxlight had 2 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 3 mentions for Boxlight and 1 mentions for TNF Pharmaceuticals. Boxlight's average media sentiment score of 1.05 beat TNF Pharmaceuticals' score of 0.67 indicating that Boxlight is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Boxlight
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
TNF Pharmaceuticals
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

6.5% of Boxlight shares are held by institutional investors. Comparatively, 9.6% of TNF Pharmaceuticals shares are held by institutional investors. 15.4% of Boxlight shares are held by company insiders. Comparatively, 0.5% of TNF Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Boxlight beats TNF Pharmaceuticals on 8 of the 12 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to AGM Group?

TNF Pharmaceuticals (NASDAQ:TNFA) and AGM Group (NASDAQ:AGMH) are both small-cap technology companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

AGM Group's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
TNF PharmaceuticalsN/A -69.21% -33.98%
AGM Group N/A N/A N/A

TNF Pharmaceuticals has a beta of 2.04, meaning that its share price is 104% more volatile than the broader market. Comparatively, AGM Group has a beta of 2.58, meaning that its share price is 158% more volatile than the broader market.

9.6% of TNF Pharmaceuticals shares are owned by institutional investors. 0.5% of TNF Pharmaceuticals shares are owned by insiders. Comparatively, 34.9% of AGM Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, AGM Group had 3 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 4 mentions for AGM Group and 1 mentions for TNF Pharmaceuticals. TNF Pharmaceuticals' average media sentiment score of 0.67 beat AGM Group's score of 0.54 indicating that TNF Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TNF Pharmaceuticals
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AGM Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

AGM Group has higher revenue and earnings than TNF Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TNF PharmaceuticalsN/AN/A-$23.36M-$231.00N/A
AGM Group$30.56M0.06$560KN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TNF Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
AGM Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

AGM Group beats TNF Pharmaceuticals on 8 of the 10 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to Wearable Devices?

TNF Pharmaceuticals (NASDAQ:TNFA) and Wearable Devices (NASDAQ:WLDS) are both small-cap technology companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TNF Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Wearable Devices
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Wearable Devices' return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
TNF PharmaceuticalsN/A -69.21% -33.98%
Wearable Devices N/A N/A N/A

9.6% of TNF Pharmaceuticals shares are held by institutional investors. Comparatively, 0.2% of Wearable Devices shares are held by institutional investors. 0.5% of TNF Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Wearable Devices has higher revenue and earnings than TNF Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TNF PharmaceuticalsN/AN/A-$23.36M-$231.00N/A
Wearable Devices$703K2.12-$8.11MN/AN/A

In the previous week, Wearable Devices had 4 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 5 mentions for Wearable Devices and 1 mentions for TNF Pharmaceuticals. TNF Pharmaceuticals' average media sentiment score of 0.67 beat Wearable Devices' score of 0.56 indicating that TNF Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TNF Pharmaceuticals
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Wearable Devices
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Wearable Devices beats TNF Pharmaceuticals on 6 of the 9 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to Ainos?

TNF Pharmaceuticals (NASDAQ:TNFA) and Ainos (NASDAQ:AIMDW) are both technology companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

In the previous week, TNF Pharmaceuticals and TNF Pharmaceuticals both had 1 articles in the media. Ainos' average media sentiment score of 1.82 beat TNF Pharmaceuticals' score of 0.67 indicating that Ainos is being referred to more favorably in the news media.

Company Overall Sentiment
TNF Pharmaceuticals Positive
Ainos Very Positive

Ainos has higher revenue and earnings than TNF Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TNF PharmaceuticalsN/AN/A-$23.36M-$231.00N/A
Ainos$13.60KN/AN/AN/AN/A

9.6% of TNF Pharmaceuticals shares are held by institutional investors. 0.5% of TNF Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Ainos' return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
TNF PharmaceuticalsN/A -69.21% -33.98%
Ainos N/A N/A N/A

Summary

Ainos beats TNF Pharmaceuticals on 4 of the 6 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to Churchill Capital Corp X/Cayman?

TNF Pharmaceuticals (NASDAQ:TNFA) and Churchill Capital Corp X/Cayman (NASDAQ:CCCXW) are both technology companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TNF PharmaceuticalsN/AN/A-$23.36M-$231.00N/A
Churchill Capital Corp X/CaymanN/AN/AN/AN/AN/A

Churchill Capital Corp X/Cayman's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
TNF PharmaceuticalsN/A -69.21% -33.98%
Churchill Capital Corp X/Cayman N/A N/A N/A

In the previous week, TNF Pharmaceuticals had 1 more articles in the media than Churchill Capital Corp X/Cayman. MarketBeat recorded 1 mentions for TNF Pharmaceuticals and 0 mentions for Churchill Capital Corp X/Cayman. TNF Pharmaceuticals' average media sentiment score of 0.67 beat Churchill Capital Corp X/Cayman's score of 0.00 indicating that TNF Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
TNF Pharmaceuticals Positive
Churchill Capital Corp X/Cayman Neutral

9.6% of TNF Pharmaceuticals shares are owned by institutional investors. 0.5% of TNF Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

TNF Pharmaceuticals beats Churchill Capital Corp X/Cayman on 4 of the 6 factors compared between the two stocks.

Get TNF Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TNFA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TNFA vs. The Competition

MetricTNF PharmaceuticalsTechnology Hardware, Storage & Peripherals IndustryTechnology SectorNASDAQ Exchange
Market Cap$1.03M$119.09B$30.19B$12.94B
Dividend YieldN/A1.72%2.77%27.63%
P/E Ratio0.0021.3762.5418.55
Price / SalesN/A68.86579.1376.22
Price / CashN/A20.8047.2051.88
Price / Book0.007.227.525.85
Net Income-$23.36M$3.49B$766.37M$380.67M
7 Day Performance-12.44%-7.86%-5.27%-4.97%
1 Month Performance26.33%-8.26%-4.15%-6.95%
1 Year Performance-88.24%33.12%161.13%-5.99%

TNF Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TNFA
TNF Pharmaceuticals
N/A$0.56
+3.3%
N/A-87.6%$1.03MN/AN/A6
BOXL
Boxlight
1.2858 of 5 stars
$3.60
-21.9%
N/A-95.1%$3.89M$109.25MN/A155
AGMH
AGM Group
0.7234 of 5 stars
$0.58
-20.2%
N/A-89.1%$2.36M$30.56MN/A11
WLDS
Wearable Devices
0.5178 of 5 stars
$1.40
+1.4%
N/A-96.2%$1.62M$703KN/A38
AIMDW
Ainos
N/A$0.08
+43.4%
N/A-80.5%$0.00$13.60KN/A41

Related Companies and Tools


This page (NASDAQ:TNFA) was last updated on 10/16/2026 by MarketBeat.com Staff.
From Our Partners